13F HOLDINGS REPORT
RP Management, LLC
Quarter ended Q4 2024 · Filed February 3, 2025 · Accession 0001507673-25-000003
Total Value
$227.7M
Positions
4
Other Managers
1
Confidential Omitted
No
Holdings (4)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BIOHAVEN LTD | BHVN | 2,936,507 | $146.7M | 64.43% |
| 2 | CYTOKINETICS, INC | CYTK | 980,392 | $51.8M | 22.73% |
| 3 | BIOCRYST PHARMACEUTICALS INC | BCRX | 3,846,154 | $29.2M | 12.84% |
| 4 | VIRACTA THERAPEUTICS INC | 92765F108 | 3,700 | $851 | 0.00% |